June 9, 2010
Wednesday FoREMS: Building REMS into Your Organization "How should we build REMS into our organization?" has become a frequent question among our clients. Two leaders in this emerging field will share their different approaches to incorporating REMS into an organization.
Wednesday FoREMS discussion
June 9, 2010 at 12:00 PM Eastern Time
Building REMS into Your Organization
"How should we build REMS into our organization?" has become a frequent question raised among our clients. This reflects a large issue developing throughout the pharmaceutical and biotech industries today. We thought it was time to open this discussion in our Wednesday FoREMS webinar series. Two leaders in this emerging field will share their different approaches to incorporating REMS into an organization.
- James Nickas, PharmD, Head Regional Center Americas, Drug Safety Operations, Genentech, Inc. Jim is managing the process of embedding REMS into Genentech in a manner that builds risk evaluation and mitigation thinking into the entire culture of clinical development itself.
- Art Morelli, Vice President Medical Affairs Operations (REMS) at Covidien. Art will discuss how Covidien uses a REMS Coordination Office and cross-functional teams to ensure that REMS is a central part of the commercialization process.
We invite you to join us and engage in this conversation as we learn what other organizations are doing to incorporate REMS into the development and commercialization of new and existing drugs.
To join us for this session, please register for the Wednesday FoREMS webinar series.
To speak to a ParagonRx team member about our monthly webinars
call 888.459.8080 or email email@example.com